Expert Discussion: SABCS 2021
- PMID: 35355701
- PMCID: PMC8914229
- DOI: 10.1159/000521762
Expert Discussion: SABCS 2021
Conflict of interest statement
Rupert BartschAdvisory Role: Astra-Zeneca, Daiichi, Eisai, Eli-Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Puma, Roche, Seagen. Lecture Honoraria: Astra-Zeneca, Eli-Lilly, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen. Research Support: Daiichi, MSD, Novartis, Roche.Cornelia Kolberg-LiedtkeHonoraria: Roche, Genomic Health, GlaxoSmithKline, AstraZeneca, Eisai, Celgene, Amgen, Gedeon Richter, Novartis, Pierre Fabre, Teva. Consulting or Advisory Role: Roche, Genomic Health, Teva, Pierre Fabre, Novartis. Research Funding: Eisai, Roche, Novartis, Boehringer Ingelheim. Travel, Accommodations, Expenses: Roche, Teva, PharmaMar, Celgene. Employment: Palleos healthcare (VP Medical and Scientific Development), Phaon scientific (Co-founder, Managing Director).Guy JerusalemResearch grants and/or honoraria from Novartis, Amgen, Roche, Pfizer, Bristol-Myers Squibb, Lilly, Astra-Zeneca, Daiichi Sankyo, Abbvie, Seagen.Carlo PalmieriGrant funding from Pfizer and Daiichi Sankyo and honoraria for advisory boards from Pfizer, Roche, Daiichi Sankyo, Novartis, AZ, Exact sciences, and Eli Lilly.Wolfgang JanniResearch Grants and/or honoraria from Sanofi-Aventis, Novartis, Roche, Pfizer, Lilly, AstraZeneca, Chugai, GSK, Eisai, Cellgene, DaiichiSankyo, MSD, Seagen, Johnson&Johnson.